Fred B Craves is Director of MADRIGAL PHARMACEUTICALS, INC.. Currently has a direct ownership of 360,076 shares of MDGL, which is worth approximately $111 Million. The most recent transaction as insider was on Sep 13, 2024, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 360K
0% 3M change
0.68% 12M change
Total Value Held $111 Million

FRED B CRAVES Transaction History

Date Transaction Value Shares Traded Shares Held Form
Sep 13 2024
SELL
Bona fide gift
-
15,000 Reduced 4.0%
360,076 Common Stock
Jun 25 2024
BUY
Grant, award, or other acquisition
-
714 Added 0.19%
375,076 Common Stock
Jun 11 2024
SELL
Bona fide gift
-
39,000 Reduced 9.43%
374,362 Common Stock
May 14 2024
SELL
Open market or private sale
$4,844,130 $215.4 p/Share
22,489 Reduced 5.16%
413,362 Common Stock
May 14 2024
BUY
Exercise of conversion of derivative security
$2,310,969 $102.76 p/Share
22,489 Added 4.91%
435,851 Common Stock
Jun 15 2023
BUY
Grant, award, or other acquisition
-
1,198 Added 0.33%
362,556 Common Stock
FBC

Fred B Craves

Director
West Conshohocken, PA

Track Institutional and Insider Activities on MDGL

Follow MADRIGAL PHARMACEUTICALS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MDGL shares.

Notify only if

Insider Trading

Get notified when an Madrigal Pharmaceuticals, Inc. insider buys or sells MDGL shares.

Notify only if

News

Receive news related to MADRIGAL PHARMACEUTICALS, INC.

Track Activities on MDGL